HonCode

Go Back   HER2 Support Group Forums > Clinical Trials
Register Gallery FAQ Members List Calendar Search Today's Posts Mark Forums Read

Reply
 
Thread Tools Display Modes
Old 09-14-2007, 06:02 PM   #1
Joe
Webmaster
 
Joe's Avatar
 
Join Date: Feb 2005
Location: Home of the "Flying Tomato" Carlsbad, CA
Posts: 2,036
Images: 5
A New Formulation of Herceptin

We received a press release today from Genentech. Christine and I spoke to the Product Manager of Herceptin at San Francisco last weekend and he was very excited about this.

Trastuzumab (Herceptin®) is a drug used to treat breast cancer in women whose tumors contain the receptor for a protein called HER2. In some women, however, the drug stops working. Researchers are therefore seeking more effective drugs for this disease.
Trastuzumab-MCC-DM1 is an investigational drug that contains trastuzumab linked to a chemotherapy drug. When trastuzumab binds to the HER2 protein, it then releases the chemotherapy drug directly to the tumor cells. Trastuzumab-MCC-DM1 has caused cancer cells to die in laboratory studies, and has prevented or slowed the growth of breast cancer in animal studies.

http://www.clinicaltrials.gov/ct/sho...509769?order=1
__________________
A Proud webmaster to the internet's most informed, educated, COMPASSIONATE and caring group of breast cancer survivors.

Illegitimi non carborundum


My Album
Joe is offline   Reply With Quote
Reply

Thread Tools
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off

Forum Jump


All times are GMT -7. The time now is 08:03 AM.


Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021
free webpage hit counter